Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Gonzalo, H; Brieva, L; Tatzber, F; Jové, M; Cacabelos, D; Cassanyé, A; Lanau-Angulo, L; Boada, J; Serrano, JC; González, C; Hernández, L; Peralta, S; Pamplona, R; Portero-Otin, M.
Lipidome analysis in multiple sclerosis reveals protein lipoxidative damage as a potential pathogenic mechanism.
J Neurochem. 2012; 123(4): 622-634.
Doi: 10.1111/j.1471-4159.2012.07934.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
-
Tatzber Franz
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
Metabolomic and lipidomic analyses have been used for the profiling of neurodegenerative processes, both in targeted and untargeted approaches. In this work we have applied these techniques to the study of CSF samples of multiple sclerosis (MS) patients (n = 9), compared with samples of non-MS individuals (n = 9) using mass-spectrometry. We have used western-blot and analyzed cell culture to confirm pathogenic pathways suggested by mass-spectrometric measurements. The results of the untargeted approach of metabolomics and lipidomics suggest the existence of several metabolites and lipids discriminating both populations. Applying targeted lipidomic analyses focused to a pathogenic pathway in MS, oxidative stress, reveal that the lipid peroxidation marker 8-iso-prostaglandin F2α is increased in CSF from MS patients. Furthermore, as lipid peroxidation exerts its pathogenical effects through protein modification, we studied the incidence of protein lipoxidation, revealing specific increases in carboxymethylated, neuroketal and malondialdehyde-mediated protein modifications in proteins of CSF from MS patients, despite the absence of their precursors glyoxal and methylglyoxal. Finally, we report that the level of neuroketal-modified proteins correlated with a hitherto unknown increased amount of autoantibodies against lipid peroxidation-modified proteins in CSF, without compensation by signaling induced by lipid peroxidation via peroxisome proliferator-activated receptor γ (PPARγ). The results, despite the limitation of being obtained in a small population, strongly suggest that autoimmunity against in situ produced epitopes derived from lipid peroxidation can be a relevant pathogenic factor in MS.
© 2012 The Authors Journal of Neurochemistry © 2012 International Society for Neurochemistry.
- Find related publications in this database (using NLM MeSH Indexing)
-
Adult -
-
Autoantibodies - cerebrospinal fluid
-
Cell Line, Transformed -
-
Chromatography, High Pressure Liquid -
-
Fatty Acids - cerebrospinal fluid
-
Female -
-
Glyoxal - analysis
-
Glyoxal - cerebrospinal fluid
-
Humans -
-
Lipid Peroxidation - immunology
-
Lipid Peroxidation - physiology
-
Lipids - cerebrospinal fluid
-
Lipids - immunology
-
Lipoproteins, LDL - immunology
-
Male -
-
Malondialdehyde - cerebrospinal fluid
-
Mass Spectrometry -
-
Metabolic Networks and Pathways -
-
Middle Aged -
-
Mucoproteins - metabolism
-
Multiple Sclerosis - cerebrospinal fluid
-
PPAR gamma - genetics
-
PPAR gamma - metabolism
-
Protein Carbonylation - physiology
-
Pyruvaldehyde - analysis
-
Pyruvaldehyde - cerebrospinal fluid
- Find related publications in this database (Keywords)
-
autoimmunity
-
lipid peroxidation
-
PPAR
-
protein oxidation